Dr. Saowanee Ngamruengphong, MD

Dr. Ngamruengphong practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Ngamruengphong's NPI, 1285898023, was assigned on July 10, 2008. Dr. Ngamruengphong holds Maryland license D81862.

Dr. Ngamruengphong's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Ngamruengphong's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Ngamruengphong is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Ngamruengphong to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ngamruengphong practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ngamruengphong's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Ngamruengphong's licenses on file in 3 states: Maryland, Florida and Texas.

CMS data shows 764 Medicare services from Dr. Ngamruengphong across 20 procedure codes in 2024, for 506 Medicare patients. Medicare paid $110,023 for them.

CMS counts 506 Medicare patients who saw Dr. Ngamruengphong in 2024. The largest group is 65 to 74, with 239 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ngamruengphong's median patient age at 73, with 53% women.

In 2024, Dr. Ngamruengphong wrote 288 Medicare Part D claims for 201 patients. 74% of them were for generic drugs. CMS names the drug for 238 of them, across 5 drugs with 11 or more claims each, at $7,925 in total drug cost. In 2023, CMS named 173 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Ngamruengphong for performance year 2024, reported as part of a group. CMS lists Dr. Ngamruengphong as offering telehealth. CMS counts 402 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ngamruengphong, more than 97% of the clinicians it reports for that procedure.

CMS Open Payments shows 195 general payments to Dr. Ngamruengphong from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Boston Scientific Corporation paid the most, $115,788.